Use

This test analyzes the NF2 gene, associated with autosomal dominant NF2-related schwannomatosis. It helps in confirming clinical diagnosis, predicting disease progression, guiding therapeutic decisions, facilitating early symptom detection in at-risk relatives, and informing family planning. The condition generally presents with multiple nervous system tumors such as schwannomas and meningiomas. Identification of a disease-causing variant aids in testing and diagnosing at-risk relatives.